Determine the necessary mass, volume, or concentration for preparing a solution.
Ixekizumab (anti-CTLA-8) (Ab175883) - ELISA
Immobilized Recombinant Human IL-17A Protein at 0.5 μg/mL can bind Ixekizumab (anti-CTLA-8) (Ab175883) with the EC₅₀ of 33.85 ng/mL.

